Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients

Table 2 Hematologic and non-hematologic toxicities of imatinib dose escalation n (%)

	Imatinib 600 mg/d		Imatinib 800 mg/d
	Grade 1-2 (%)	Grade 3-4 (%)	Grade 1-2 (%)	Grade 3-4 (%)
Edema	42 (80.8)	0 (0)	14 (100)	0 (0)
Fatigue	32 (61.5)	1 (1.9)	9 (64.3)	5 (35.7)
Granulocytopenia	19 (36.5)	3 (5.8)	5 (35.7)	1 (7.1)
Skin rash	12 (23.1)	2 (3.8)	7 (50.0)	1 (7.1)
Anemia	7 (13.5)	2 (3.8)	5 (35.7)	0 (0)
Thrombocytopenia	2 (3.8)	0 (0)	1 (7.1)	0 (0)
Anorexia	8 (15.4)	1 (1.9)	6 (42.9)	0 (0)
Nausea	11 (21.2)	1 (1.9)	6 (42.9)	0 (0)
Alopecia	0 (0)	0 (0)	2 (14.3)	0 (0)
Abdominal pain	11 (21.2)	0 (0)	7 (50.0)	0 (0)
Diarrhea	5 (9.6)	0 (0)	1 (7.1)	0 (0)
Epiphora	2 (3.8)	0 (0)	2 (14.3)	0 (0)